0 likes | 1 Vues
Nabil Lally, Senior Director of Business Development at Quotient Sciences, is redefining the pace and precision of early-phase drug development. Through the Translational Pharmaceuticsu00ae platform, he empowers biotech and pharma teams to integrate formulation, manufacturing, and clinical testingu2014cutting timelines by up to 12 months. <br><br>https://x.com/PharmoreTweets
E N D